My Market Wizard

GSK plc 6-K Analysis & Summary – 2/21/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

GSK plc

Filing date:

02/21/2025

TLDR:

GSK plc reports the vesting of deferred bonus awards and subsequent sale of ordinary shares and American Depositary Shares by Persons Discharging Managerial Responsibilities to meet tax liabilities.

ELI5:

GSK gave some of its managers bonuses in the form of shares a few years ago, which they couldn’t access until now. Now that the time has passed, the managers are getting those shares, but they’re selling some of them right away to pay the taxes on the bonus.

Accession #:

0001654954-25-001724

Published on

Analyst Summary

  • Vesting of Deferred Bonus Awards for PDMRs (Persons Discharging Managerial Responsibilities) over Ordinary Shares and American Depositary Shares (ADSs).
  • Awards were granted in 2022 under the GlaxoSmithKline 2017 Deferred Annual Bonus Plan (DABP).
  • The three-year restricted period for the awards commenced on 15 February 2022 and ended on 17 February 2025 for Ordinary Shares and 18 February 2025 for ADSs.
  • Awards comprised a mandatory bonus deferral only, in accordance with the shareholder approved 2017 Remuneration Policy and the DABP rules.
  • Subsequent sale of Ordinary Shares and ADSs by PDMRs to meet tax liabilities.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️